type density location immune cells within human colorectal tumors predict clinical outcome 
role adaptive immune response controlling growth recurrence human tumors controversial characterized tumor-infiltrating immune cells large cohorts human colorectal cancers gene expression profiling situ immunohistochemical staining collectively immunological data type density location immune cells within tumor samples found better predictor patient survival histopathological methods currently used stage colorectal cancer results validated two additional patient populations data support hypothesis adaptive immune response influences behavior human tumors situ analysis tumor-infiltrating immune cells may therefore valuable prognostic tool treatment colorectal cancer possibly malignancies 
